Figures & data
Figure 1 Current strategies for the management of IFI in high-risk patients.
Notes: *High-resolution computed tomography scan of the lungs showing new ≥1 cm single or multiple nodules with or without halo sign, lobar consolidation, wedge-shaped consolidative infarct; **classic example: patients with proglonged and profound neutropenia after intense chemotherapy for hematologic malignancy.
Abbreviations: GM, serum Galactomannan; IFI, invasive fungal infection; PCR, polymerase chain reaction.
![Figure 1 Current strategies for the management of IFI in high-risk patients.Notes: *High-resolution computed tomography scan of the lungs showing new ≥1 cm single or multiple nodules with or without halo sign, lobar consolidation, wedge-shaped consolidative infarct; **classic example: patients with proglonged and profound neutropenia after intense chemotherapy for hematologic malignancy.Abbreviations: GM, serum Galactomannan; IFI, invasive fungal infection; PCR, polymerase chain reaction.](/cms/asset/94c99107-0813-4f6a-90a6-2d0d6aeb107a/didr_a_22587_f0001_b.jpg)
Table 1 US Food and Drug Administration-approved indication of antifungal agents for the management of IFIs
Table 2 Summary of clinical trials comparing efficacy and safety of liposomal amphotericin B with other antifungal agents for empirical antifungal therapy in patients with neutropenia